About Inner Mongolia Furui Medical Science
Inner Mongolia Furui Medical Science is a company based in Beijing (China) founded in 1998. The company has 879 employees as of December 31, 2024. Inner Mongolia Furui Medical Science has completed 1 acquisition, including EchoSens. Inner Mongolia Furui Medical Science operates in a competitive market with competitors including EchoSens, Fibronostics, Glycotest, Bilhi Genetics and Wuxi Hisky Medical, among others.
- Headquarter Beijing, China
- Employees 879 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Inner Mongolia Furui Medical Science Co., Ltd. Class A
-
Annual Revenue
$183.58 M (USD)17.28as on Dec 31, 2024
-
Net Profit
$15.52 M (USD)11.54as on Dec 31, 2024
-
EBITDA
$52.05 M (USD)13.37as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
879
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Inner Mongolia Furui Medical Science
Inner Mongolia Furui Medical Science is a publicly listed company on the SZSE with ticker symbol 300049 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Inner Mongolia Furui Medical Science
Detailed funding history for Inner Mongolia Furui Medical Science
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Inner Mongolia Furui Medical Science
Inner Mongolia Furui Medical Science has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include EchoSens.
Investment portfolio details for Inner Mongolia Furui Medical Science
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Non-invasive diagnostics for liver disease detection are developed.
|
Locked | Locked | 2001 | Locked |
Complete acquisition details for Inner Mongolia Furui Medical Science
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Inner Mongolia Furui Medical Science
Detailed financials for Inner Mongolia Furui Medical Science
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Inner Mongolia Furui Medical Science Comparisons
Peer comparison for Inner Mongolia Furui Medical Science
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Inner Mongolia Furui Medical Science
Inner Mongolia Furui Medical Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EchoSens, Fibronostics, Glycotest, Bilhi Genetics and Wuxi Hisky Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive diagnostics for liver disease detection are developed.
|
|
| Locked | Locked | Locked |
Non-invasive algorithm-based diagnostics
|
|
| Locked | Locked | Locked |
Non-invasive blood tests for liver cancers and fibrosis-cirrhosis are provided.
|
|
| Locked | Locked | Locked |
Genetic markers are utilized for disease prediction algorithms.
|
|
| Locked | Locked | Locked |
Non-invasive liver diagnosis systems are manufactured using TE technology.
|
Detailed competitors of Inner Mongolia Furui Medical Science
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inner Mongolia Furui Medical Science
Complete news archive for Inner Mongolia Furui Medical Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inner Mongolia Furui Medical Science
Inner Mongolia Furui Medical Science was founded in 1998.
Inner Mongolia Furui Medical Science is headquartered in Beijing, China.
As of Dec 31, 2024, the latest employee count at Inner Mongolia Furui Medical Science is 879.
Annual revenue of Inner Mongolia Furui Medical Science is $183.58M as on Dec 31, 2024.
Founded in 1998 and based in Beijing, China, Inner Mongolia Furui Medical Science operates in the medical technology sector. Therapeutic and diagnostic solutions for liver diseases are developed and supplied. FibroScan, a non-invasive device, is utilized with shear-wave elastography to evaluate liver fibrosis and track disease progression. FAST and aMAP calculators are also offered to assess fatty liver conditions, identify high-risk liver cancer patients, and support general liver health monitoring.
Inner Mongolia Furui Medical Science's top competitors include EchoSens, Fibronostics and Glycotest.
Yes, Inner Mongolia Furui Medical Science is publicly traded on SZSE under the ticker symbol 300049.
Inner Mongolia Furui Medical Science has made 1 acquisition, including EchoSens.
The ticker symbol of Inner Mongolia Furui Medical Science is 300049 on SZSE.